ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606699 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606699; 2) Community: the network communities that were significantly associated with the response to NSC 606699; 3) Molecule: the relationships between components within communities and NSC 606699; 4) MDR: the compounds that were significantly associated with the NSC 606699.

NSC Compound Enrichment Correlation
NSC 671898 Null 0.00289834947687851 0.301156
NSC 127128 Null 0.00289834947687855 0.38290219
NSC 276382 PEPLEOMYCIN 0.00289834947687855 0.29293469
NSC 294979 BLEOMYCIN-BAPP 0.00289834947687855 0.21478698
NSC 305222 Cytochalasin H 0.00289834947687855 0.38864189
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.00334162892839391 0.27133174
NSC 734982 Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate 0.00334162892839391 0.31775836
NSC 606499 Camptothecin Derivative 0.00337662564965909 0.028948125
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.00337662564965909 -0.059492844
NSC 759878 Irinotecan hydrochloride (USAN) 0.00337662564965909 0.13673901
Total:56  Current:6    [First] [Prev] [Next] [Last]